FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Revised Proposal Requests for Reimporting Insulin

Federal Register notice: FDA and HHS revise proposal requests for reimporting insulin and the personal importation of prescription drugs.

Human Drugs

FDA Denies Glaxo Zofran Petition

FDA denies a GlaxoSmithKline petition asking the agency to review specified information about its Zofran and indicate whether there should be labeling...

Human Drugs

FDA Approves Merck Verquvo for Heart Failure

FDA approves Mercks Verquvo heart failure drug based on VICTORIA trial results.

Biologics

Lillis Foundation Asks C. Difficile Treatment Actions

The Peggy Lillis C. diff foundation asks FDA to take specific actions to improve the availability of microbiome treatments for C. difficile infections...

Human Drugs

Histogen Notified of FDA Clinical Hold on IND Trial

FDA notifies Histogen verbally of a coming clinical hold on its planned Phase 1/2 trial of HST-003.

Federal Register

Rule on Tobacco Product Substantial Equivalence

Federal Register notice: FDA issues a final rule to provide additional information on the content and format of reports intended to demonstrate substa...

Human Drugs

GSK Waits for Inspection to Complete Dostarlimab Review

FDA defers a review action on GlaxoSmithKlines PD-1 drug dostarlimab, indicated for treating endometrial cancer, because it could not conduct a manufa...

FDA General

Report Chronicles Hahns Politicized Career at FDA

A Vanity Fair special report examines how former FDA commissioner Stephen Hahn became the most politicized commissioner in recent history and describe...

Medical Devices

Eitan Medical Upgraded Sapphire Pump Cleared

FDA clears an Eitan Medical 510(k) for its upgraded Sapphire infusion pump system and software Rev15, which includes pump, administration sets and acc...

Human Drugs

Flawless Product Launch Helps Commercial Success: Consultants

L.E.K. consulting says better product launches are a key to profits in drug development over the last 15 years.